✦ LIBER ✦

Remitting activity of lenalidomide in treatment-induced myelodysplastic syndrome

✍ Scribed by Melchert, M; Williams, C; List, A

Book ID: 110057193
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 82 KB
Volume: 21
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404677

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of Lenalidomide in the Treatment of

Role of Lenalidomide in the Treatment of Myelodysplastic Syndromes

✍ Rami S. Komrokji; Alan F. List 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 876 KB

Lenalidomide active in myelodysplastic s

Lenalidomide active in myelodysplastic syndrome without 5q deletion

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Lenalidomide for Treatment of Myelodyspl

Lenalidomide for Treatment of Myelodysplastic Syndromes: Current Status and Future Directions

✍ Komrokji, Rami S.; List, Alan F. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Treatment by Lenalidomide in lower risk

Treatment by Lenalidomide in lower risk myelodysplastic syndrome with 5q deletion—The GFM experience

✍ Fabien Le Bras; Marie Sebert; Charikleia Kelaidi; Thierry Lamy; François Dreyfus 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 197 KB

Relationship of Treatment-Related Cytope

Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes

✍ Sekeres, M. A.; Maciejewski, J. P.; Giagounidis, A. A.N.; Wride, K.; Knight, R.; 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 133 KB

Practical recommendations on the use of

Practical recommendations on the use of lenalidomide in the management of myelodysplastic syndromes

✍ Aristoteles Giagounidis; Pierre Fenaux; Ghulam J. Mufti; Petra Muus; Uwe Platzbe 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 167 KB